VANCOUVER, BC--(Marketwired - April 04, 2016) - THC BioMed Intl Ltd. ("THC") (
Affinor is a diversified agriculture and biotechnology company with proprietary state of the art automated vertical farming systems. The intention of the agreement is that Affinor will install, showcase and develop the technology under commercial conditions to ensure capabilities for the low-cost mass production of cannabis and cannabis products. THC BioMed recently received its federal license from Health Canada to cultivate medical marijuana and has selected Affinor's equipment to be a leader in high quality mass production of cannabis and cannabis products as the market continues to grow.
"THC is excited to work with Affinor on introducing its vertical grow technology into the cannabis industry. We feel this is a perfect fit of science and technology for both highly qualified teams," states John Miller, CEO of THC.
THC's vision is to be on the leading edge of scientific research and development of products and services related to the medical cannabis industry while creating a standard of excellence. As the industry develops, it will become more important to focus on scientific research and development of products and services related to medical cannabis. Management believes THC is well positioned to be in the forefront of this rapidly growing industry. Please visit our website for a more detailed description of our business and services available.
Please visit our website for a more detailed description of our business and services available. www.thcbiomed.com.
Forward-Looking Information:
This press release contains certain "forward-looking information" within the meaning of applicable securities law. The forward looking statements include that (i) THC will install Affinor's vertical farming system into THC's facility and (ii) Affinor's automated, state of the art vertical farming equipment to be a leader in high quality mass production of cannabis and cannabis products. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "would", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. These statements are based on expectations and assumptions made by the management of THC at the date the information is provided, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. For a description of the risks and uncertainties facing THC and its business and affairs, readers should refer to THC's Listing Statement, Financial Statements and its Management's Discussion and Analysis on www.sedar.com.
Contact Information:
President and CEO:
John Miller
THC Biomed Intl Ltd.
T: 604 682-1643
E: info@thcbiomed.com